Cipla Limited (CIPLA.BO)

1,533.80 +36.50 (+2.44%) 收市：03:43PM IST

Cipla Limited

Cipla House
Peninsula Business Park Ganpatrao Kadam Marg Lower Parel
Mumbai 400013
India
91 22 2482 6000
https://www.cipla.com

版塊: Healthcare
行業: Drug Manufacturers - General
全職員工: 

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Umang Vohra B.E., M.B.A.	MD, Global CEO & Executive Director	174.9M	無	1971
Dr. Raju Sunil Mistry M.A., Ph.D.	President & Global Chief People Officer	無	無	1965
Mr. Pradeep Bhadauria	President & Chief Scientific Officer	無	無	無
Mr. Ashish Adukia	Global Chief Financial Officer	無	無	無
Mr. Dinesh Ramniranjan Jain	Senior VP & Head of Corporate Finance	無	無	無
Ms. Geena V. Malhotra	Global Chief Technology Officer	無	無	無
Mr. Naveen Bansal	Head of Investor Relations	無	無	無
Mr. Rajendra Kumar Chopra	Compliance Officer & Company Secretary	15.3M	無	無
Ms. Heena Kanal	Senior Vice-President of Corporate Communications	無	無	無
Mr. Anurag Mishra	Head of Cipla Foundation	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 INR。

描述

Cipla Limited, together with its subsidiaries, manufactures, develops, and sells pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New ventures segments. It also offers active pharmaceutical ingredients; and formulations in various therapeutic areas, such as MI, angina, heart failure, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, HIV, respiratory, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. In addition, the company provides respiratory products, including inhalers and nasal sprays, as well as other respiratory products consists of injectables and biosimilars. Further, it offers Easylax and Easylax L, a liquid paraffin for constipation. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.

公司管治

截至 2024年6月1日 止，Cipla Limited 的 ISS 管治質素評分為 3。 Pillar 分數正在審核中：4；董事會：2；股東權利：1；現金賠償：8。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。